أخبار

  1. Aug. 11, 2021

    Organ perfusion systems a boon to heart and lung transplants

    Transplant specialists at Mayo Clinic in Florida use organ perfusion systems for some heart and lung transplants, resulting in multiple advantages for recipients — including saving lives.

  2. July 31, 2021

    Pulmonary function laboratories offer comprehensive testing services with advanced diagnostics

    Mayo Clinic pulmonary function laboratories' updated infection control practices in response to COVID-19 allowed needed testing services to reopen quickly and personal protective measures to be de-escalated safely.

  3. July 31, 2021

    New treatment options for patients with obstructive sleep apnea who are intolerant to positive airway pressure therapy

    Mayo Clinic offers upper airway stimulation therapy, oral appliance therapy and the expertise of a sleep surgeon for patients who are positive airway pressure (PAP) therapy intolerant.

  4. July 31, 2021

    Establishing the pulmonary oncologic toxicity clinic to care for patients with lung toxicity

    Mayo Clinic Pulmonary and Critical Care Medicine is establishing a pulmonary oncologic toxicity clinic to care for patients with lung toxicity from chemotherapy, radiation and immunotherapy.

  5. April 03, 2021

    Expiratory central airway collapse is challenging to identify and underdiagnosed

    Dynamic flexible bronchoscopy is the diagnostic criterion standard for expiratory central airway collapse, which can coexist with and mimic asthma, chronic obstructive pulmonary disease and bronchiectasis.

  6. April 03, 2021

    Mayo Clinic Pulmonary and Critical Care Medicine's commitment to clinical practice excellence, education enhancement and research advancement

    Mayo Clinic is one of the few U.S. centers experienced in successful performance of balloon pulmonary angioplasties for patients with nonoperable chronic thromboembolic pulmonary hypertension.

  7. April 03, 2021

    Cough Clinic employs novel pharmacologics to address unexplained or refractory chronic cough

    Mayo Clinic Cough Clinic specialists research and employ novel pharmacologic treatments and collaborate with Otolaryngology colleagues to address frustrating unexplained or refractory chronic cough.

  8. Nov. 19, 2020

    Patient-specific airway stents created using 3D printing technology

    Mayo Clinic is one of the first centers to offer patients with complex central airway stenosis patient-specific, customized airway stents approved by the Food and Drug Administration.

  9. April 03, 2020

    Mayo Clinic on the path to personalization of mechanical ventilation

    As mortality improvements in acute respiratory distress syndrome have stagnated and the concept of safe ventilation continues to evolve, the search for better and more-integrative therapeutic targets has ensued.

  10. April 03, 2020

    Regenerative medicine in lung diseases

    Research supports that it is safe and feasible to provide cell therapy intravenously to lung transplant recipients who have developed chronic lung allograft dysfunction.

  11. April 03, 2020

    The gut-lung axis: Intestinal microbiota and inflammatory lung disease

    In this Q and A, Mayo Clinic pulmonologist Joseph H. Skalski, M.D., discusses research into intestinal bacterial and fungal microbiota in patients with obstructive disease phenotypes.

  12. April 03, 2020

    Update on ICU sedation

    At Mayo Clinic, the mechanical ventilation order set in the ICU no longer includes mandatory use of sedative medications.

  13. April 03, 2020

    Home sleep apnea test simplifies diagnosing obstructive sleep apnea

    Mayo Clinic Center for Sleep Medicine innovation reduces the time and effort patients expend in obtaining accurate diagnoses and personalized treatment plans for obstructive sleep apnea.

  14. Feb. 25, 2020

    Molecular Detection for Tuberculosis Drug Resistance [A Test in Focus]

    Mayo Clinic Laboratories' whole-genome sequencing testing provides molecular detection of well-characterized drug resistance variants in Mycobacterium tuberculosis complex by sequencing Mycobacterium tuberculosis isolat[...]

  15. Dec. 10, 2019

    Researchers discover distinct pathways in lung adenocarcinoma

    Discovery of distinct pathways in lung adenocarcinoma may help improve targeted cancer therapies: Mayo Clinic Forefront cancer magazine.

  16. Oct. 18, 2019

    Updates in interstitial lung disease: Current facets of anti-fibrotic therapy

    Teng Moua, M.D., discusses recent clinical trials and current research into the treatment of idiopathic pulmonary fibrosis (IPF) and non-IPF-progressive interstitial lung diseases.

  17. Oct. 15, 2019

    Ion robotic bronchoscopy system the focus of a multicenter trial

    Mayo Clinic has joined five other medical centers to conduct a multicenter trial, enrolling 300 patients to prospectively evaluate the use of a robotic bronchoscopy system.

  18. Oct. 15, 2019

    Management of fibrosing mediastinitis

    Specialists at Mayo Clinic have used off-label rituximab to treat nearly 30 patients with fibrosing mediastinitis successfully. Disease progression was almost universally halted and two-thirds of the patients improved s[...]

  19. Oct. 15, 2019

    Pediatric sleep medicine integrates with multidisciplinary clinics to facilitate communication and treatment

    Mayo Clinic's Center for Sleep Medicine team provides multidisciplinary care for children in special populations or with medically complex needs.

  20. Oct. 15, 2019

    Advancing care in chronic obstructive pulmonary disease

    Mayo Clinic's home-based pulmonary rehabilitation program provides patients who have chronic obstructive pulmonary disease (COPD) with a health coach and a computer-guided activity and monitoring program.

  21. Sept. 18, 2018

    New technology overcomes false-positives in CT for lung cancer

    Mayo researchers find that radiomics technology may help overcome false-positives in CT-based lung cancer screening: Mayo Clinic Forefront cancer magazine.

  22. Mayo Clinics Cystic Fibrosis Foundation-designated CF care center

    Mayo Clinics Cystic Fibrosis Foundation-designated CF care center

  23. Care of the patient with lung cancer at Mayo Clinic Mayo Clinic tumor board provides multidisciplinary expertise

    Care of the patient with lung cancer at Mayo Clinic Mayo Clinic tumor board provides multidisciplinary expertise

  24. Lung transplantation Challenges and opportunities

    Lung transplantation Challenges and opportunities

  25. Advances in lung cancer immunotherapy and management of immune-mediated adverse events

    Advances in lung cancer immunotherapy and management of immune-mediated adverse events

  26. Pulmonary vascular complications of chronic liver disease

    Pulmonary vascular complications of chronic liver disease

  27. Cone-beam CT for enhanced bronchoscopic access to pulmonary nodules

    Cone-beam CT for enhanced bronchoscopic access to pulmonary nodules

  28. The gaining popularity of oral appliances

    The gaining popularity of oral appliances

  29. Anti-fibrotic therapy in the treatment of IPF Ongoing concerns and current practices

    Anti-fibrotic therapy in the treatment of IPF Ongoing concerns and current practices

  30. Transbronchial cryobiopsy in diffuse parenchymal lung disease

    Transbronchial cryobiopsy in diffuse parenchymal lung disease

  31. Maxillomandibular advancement surgery A classic procedure refined

    Maxillomandibular advancement surgery A classic procedure refined

  32. Bronchoscopic lung volume reduction therapy approved for severe emphysema

    Bronchoscopic lung volume reduction therapy approved for severe emphysema

  33. New definitions and diagnoses in interstitial pneumonia

    New definitions and diagnoses in interstitial pneumonia

  34. Alpha 1 antitrypsin deficiency A liver lung connection

    Alpha 1 antitrypsin deficiency A liver lung connection

  35. The emerging option of upper airway stimulation therapy

    The emerging option of upper airway stimulation therapy

  36. Update on the management of ANCA-associated vasculitis

    Update on the management of ANCA-associated vasculitis

  37. Update in pleural disease

    Update in pleural disease

  38. Anti-interleukin-5 therapy for severe asthma A new therapeutic option

    Anti-interleukin-5 therapy for severe asthma A new therapeutic option

  39. Multidisciplinary care of idiopathic subglottic stenosis

    Multidisciplinary care of idiopathic subglottic stenosis

  40. Noninvasive radiologic biomarkers to individualize lung cancer therapy

    Noninvasive radiologic biomarkers to individualize lung cancer therapy

  41. Advancements in localization of peripheral pulmonary nodules for diagnosis and treatment

    Advancements in localization of peripheral pulmonary nodules for diagnosis and treatment